Elizabeth Waterhouse, MD

Elizabeth Waterhouse, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Alan Towne, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Correspondence: Elizabeth Waterhouse, MD, Professor, Department of Neurology, Virginia Commonwealth University, P.O. Box 980599, Richmond, VA 23298; ejwaterh@hsc.vcu.edu

Dr. Waterhouse has received grant/research support from the Ortho-McNeil and GlaxoSmithKline corporations; serves as a consultant to the UCB Pharma corporation; and is on the speakers’ bureaus of the Ortho-McNeil, Endo, Pfizer, and UCB Pharma corporations.

Dr. Towne has received grant/research support from the GlaxoSmithKline, Ortho-McNeil, Novartis, Elan, and UCB Pharma corporations and from the RW Johnson Pharmaceutical Research Institute; serves as a consultant to the Parexel, UCB Pharma, Ortho-McNeil, Elan, and AstraZeneca corporations; and is on the speakers’ bureaus of the Pharmacia, UCB Pharma, Pfizer, Ortho-McNeil, Novartis, GlaxoSmithKline, and AstraZeneca corporations.

Elizabeth Waterhouse, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Alan Towne, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Correspondence: Elizabeth Waterhouse, MD, Professor, Department of Neurology, Virginia Commonwealth University, P.O. Box 980599, Richmond, VA 23298; ejwaterh@hsc.vcu.edu

Dr. Waterhouse has received grant/research support from the Ortho-McNeil and GlaxoSmithKline corporations; serves as a consultant to the UCB Pharma corporation; and is on the speakers’ bureaus of the Ortho-McNeil, Endo, Pfizer, and UCB Pharma corporations.

Dr. Towne has received grant/research support from the GlaxoSmithKline, Ortho-McNeil, Novartis, Elan, and UCB Pharma corporations and from the RW Johnson Pharmaceutical Research Institute; serves as a consultant to the Parexel, UCB Pharma, Ortho-McNeil, Elan, and AstraZeneca corporations; and is on the speakers’ bureaus of the Pharmacia, UCB Pharma, Pfizer, Ortho-McNeil, Novartis, GlaxoSmithKline, and AstraZeneca corporations.

Elizabeth Waterhouse, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Alan Towne, MD
Department of Neurology, Virginia Commonwealth University, Richmond, VA

Correspondence: Elizabeth Waterhouse, MD, Professor, Department of Neurology, Virginia Commonwealth University, P.O. Box 980599, Richmond, VA 23298; ejwaterh@hsc.vcu.edu

Dr. Waterhouse has received grant/research support from the Ortho-McNeil and GlaxoSmithKline corporations; serves as a consultant to the UCB Pharma corporation; and is on the speakers’ bureaus of the Ortho-McNeil, Endo, Pfizer, and UCB Pharma corporations.

Dr. Towne has received grant/research support from the GlaxoSmithKline, Ortho-McNeil, Novartis, Elan, and UCB Pharma corporations and from the RW Johnson Pharmaceutical Research Institute; serves as a consultant to the Parexel, UCB Pharma, Ortho-McNeil, Elan, and AstraZeneca corporations; and is on the speakers’ bureaus of the Pharmacia, UCB Pharma, Pfizer, Ortho-McNeil, Novartis, GlaxoSmithKline, and AstraZeneca corporations.